ResearcherXuzhou Medical CollegeActive in the last 2 years

Jie Gao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1317-2445; OpenAlex author ID A5066565410. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer. Co-author DOI 10.3389/fphar.2025.1576587 ↗
MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic cancer. Co-author DOI 10.1038/s41598-024-52729-6 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jin Du · 1 shared paper, 2025 · strength 0.28
- Paper Preclinical studies of a PARP-targeted theranostic radiopharmaceutical for pancreatic cancer. DOI 10.3389/fphar.2025.1576587 ↗
Zhicheng Liu · 1 shared paper, 2024 · strength 0.24
- Paper MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic can… DOI 10.1038/s41598-024-52729-6 ↗
Lei Wang · 1 shared paper, 2024 · strength 0.24
- Paper MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic can… DOI 10.1038/s41598-024-52729-6 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.